Quality of life and comorbidity in localized malignant melanoma: Results of a German population-based cohort study

International Journal of Dermatology

Volumn 52, Issue 6, 2013, Pages 693-704

  Schubert Fritschle, Gabriele ^a   Schlesinger Raab, Anne ^a   Hein, Rüdiger ^b   Stolz, Wilhelm ^c   Volkenandt, Matthias ^a   Hölzel, Dieter ^a   Engel, Jutta ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Klinikum Schwabing   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLERGY; ARTHRALGIA; ARTICLE; BLADDER DISEASE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER REGISTRY; CANCER SURGERY; CHRONIC DISEASE; CHRONIC LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY DISEASE; LOW BACK PAIN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MELANOMA; POPULATION RESEARCH; PREDICTIVE VALUE; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATIC DISEASE; SEX DIFFERENCE; THYROID DISEASE;

ADULT; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; GERMANY; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 84878137710     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05401.x     Document Type: Article

References (43)

1. Robert-Koch Institute, Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V., eds. Krebs in Deutschland 2003-2004. Häufigkeiten und Trends, 6th edn. Berlin: Robert-Koch Institute, 2008: 50-54.
2. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute, 2008.
3. Tumorregister München. Tumor-specific analyses. http://www.tumorregister-muenchen.de/facts/surv/surv_C43__G.pdf. [Accessed July 30, 2010.]
4. Härtl K, Engel J, Herschbach P, et al. Personality traits and psychosocial stress: quality of life over 2years following breast cancer diagnosis and psychological impact factors. Psychooncology 2010; 19: 160-169.
5. Coates A, Thomson D, McLeod GR, et al. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993; 29A: 1731-1734.
6. Beusterien KM, Ackerman SJ, Plante K, et al. The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma. Support Care Cancer 2003; 11: 304-312.
7. Trask PC, Paterson AG, Esper P, et al. Longitudinal course of depression, fatigue, and quality of life in patients with high-risk melanoma receiving adjuvant interferon. Psychooncology 2004; 13: 526-536.
8. Dixon S, Walters SJ, Turner L, et al. Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomized trial. Br J Cancer 2006; 94: 492-498.
9. Cole BF, Gelber RD, Kirkwood JM, et al. Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol 1996; 14: 2666-2673.
10. Kilbridge KL, Cole BF, Kirkwood JM, et al. Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data. J Clin Oncol 2002; 20: 1311-1318.
11. Chiarion-Sileni V, Del Bianco P, De Salvo GL, et al. Quality of life evaluation in a randomized trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer 2003; 39: 1577-1585.
12. Kiebert GM, Jonas DL, Middleton MR. Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazine. Cancer Invest 2003; 21: 821-829.
13. Noorda EM, Van Kreij RH, Vrouenraets BC, et al. The health-related quality of life of longterm survivors of melanoma treated with isolated limb perfusion. Eur J Surg Oncol 2007; 33: 776-782.
14. Hobbs FD, Kenkre JE, Roalfe AK, et al. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002; 23: 1867-1876.
15. Dobre D, De Jongste MJ, Haaijer-Ruskamp FM, et al. The enigma of quality of life in patients with heart failure. Int J Cardiol 2008; 125: 407-409.
16. Johansson P, Dahlstrom U, Brostrom A. Factors and interventions influencing health-related quality of life in patients with heart failure: a review of the literature. Eur J Cardiovasc Nurs 2006; 5: 5-15.
17. Hayes DK, Denny CH, Keenan NL, et al. Health-related quality of life and hypertension status, awareness, treatment, and control: National Health and Nutrition Examination Survey, 2001-2004. J Hypertens 2008; 26: 641-647.
18. Wändell PE. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 2005; 23: 68-74.
19. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15: 205-218.
20. Goldney RD, Phillips PJ, Fisher LJ, et al. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004; 27: 1066-1070.
21. Michelson H, Bolund C, Nilsson B, et al. Health-related quality of life measured by the EORTC QLQ-C30 - reference values from a large sample of Swedish population. Acta Oncol 2000; 39: 477-484.
22. Groenvold M, Klee MC, Sprangers MA, et al. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50: 441-450.
23. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5: 555-567.
24. Sprangers MAG, Groenvold M, Arraras JI, et al. The European organisation for research and treatment of cancer: breast cancer specific quality of life questionnaire module: first results from a three-country field study. J Clin Oncol 1996; 14: 2756-2768.
25. Kerr J, Engel J, Schlesinger-Raab A, et al. Doctor-patient communication: results of a four-year prospective study in rectal cancer patients. Dis Colon Rectum 2003; 46: 1038-1046.
26. Kerr J, Engel J, Schlesinger-Raab A, et al. Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients. Ann Oncol 2003; 14: 421-427.
27. Hopwood P, Fletcher I, Lee A, et al. A body image scale for use with cancer patients. Eur J Cancer 2001; 37: 189-197.
28. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
29. Fayers P, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 Scoring Manual. Brussels: EORTC, 1995.
30. Curran D, Aaronson N, Standaert B, et al. Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study. Eur J Cancer 2000; 36: 834-844.
31. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345-1351.
32. Hjermstad MJ, Fayers PM, Bjordal K, et al. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ-C30 (+3). J Clin Oncol 1998; 16: 1188-1196.
33. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-144.
34. Maisey NR, Norman A, Watson M, et al. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002; 38: 1351-1357.
35. Ellert U, Bellach BM. [The SF-36 in the Federal Health Survey - description of a current normal sample]. Gesundheitswesen 1999; 61: 184-190.
36. Brorsson B, Ifver J, Hays RD. The Swedish Health-Related Quality of Life Survey (SWED-QUAL). Qual Life Res 1993; 2: 33-45.
37. Lee KA, Kryger MH. Women and sleep. J Womens Health (Larchmt) 2008; 17: 1189-1190.
38. Phillips BA, Collop NA, Drake C, et al. Sleep disorders and medical conditions in women. Proceedings of the Women and Sleep Workshop, National Sleep Foundation, Washington, DC, March 5-6, 2007. J Womens Health (Larchmt) 2008; 17: 1191-1199.
39. McCrea GL, Miaskowski C, Stotts NA, et al. A review of the literature on gender and age differences in the prevalence and characteristics of constipation in North America. J Pain Symptom Manage 2009; 37: 737-745.
40. Fossa SD, Hess SL, Dahl AA, et al. Stability of health-related quality of life in the Norwegian general population and impact of chronic morbidity in individuals with and without a cancer diagnosis. Acta Oncol 2007; 46: 452-461.
41. Gorkin L, Norvell NK, Rosen RC, et al. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol 1993; 71: 1069-1073.
42. Brorsson B, Bernstein SJ, Brook RH, et al. Quality of life of patients with chronic stable angina before and four years after coronary revascularization compared with a normal population. Heart 2002; 87: 140-145.
43. Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, et al. Respiratory symptoms, COPD severity, and health-related quality of life in a general population sample. Respir Med 2008; 102: 399-406.